Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
Interesting project. I love the concept - combine treatments in a rational way to make them work better. Of course, this is only in mice, which you can not rely on to say it will work in people, but I think it deserves a human trial. This is the type of thing we can do with the the Virtual trial since both treatments are easily available. We have 5 patients who tried that combination. It is hard to say if it helped - we need more people..
** Note: date changed to March 9!!!!!!***
The Florida Brain Tumor Association (FBTA) is hosting their yearly conference, "Progress Against Brain Tumors" , March . 9, 2013. This is from our friends at the FBTA. They always put on a great conference. Definately worth going to. I talk to a lot of people who do not realize how valuable these patient conferences are until they actually go to one. Aside from the educational aspect, there is a social benefit. You will get to meet many other families going through the same thing as you! You can go without feeling self concious about scars, speach problems, wheelchair, bald spot or anything. You will have a lot in common with others to make it easy to meet people and talk to people.
The Musella Foundation - in partnership with the CNJBTSG will have our patient conference in NJ in the fall. Will let you know when we set the date!
